News

Ideas That Generate Results

With continued improvements, WGS is likely to be used in Acute Myeloid Leukemia (AML) and other rare cancers to detect mutations and guide treatment. In future, it is even possible that WGS would become standard practice for the management of most cancer cases. However, there are some key challenges that need to be tackled if the market has to prosper. At this point, start-up costs for WGS are still significant, and therefore, there is a dire need to build a strong framework for a price mechanism in collaboration between private and public players. Other than the cost-related concern, ethical issues will also need consideration while the technology becomes more common. Last but not the least, patients as well as oncologists will need to be educated in order to increase awareness surrounding the technology.
 
Our report entitled “US Personalized Cancer Genome Sequencing Market Outlook 2018” entails detailed study of current and future cancer prevalence and incidences across US. In addition, it provides an insight about the leading states with cancer incidences. Also covered is age wise statistics for cancer and comprehensive figures for cancer in males and females. Further, we have provided potential states for whole genome sequencing to help market players gauge maximum opportunity for growth. Besides, the report also provides potential customer base and the market’s growth potential for personalized cancer WGS till 2018.
 
The regulatory landscape has been closely monitored which requires consideration of the authorities over genome based tests. Further, we have also discussed the various constraints faced by the industry players with suitable suggestions to overcome them. The report analyzes the competitive landscape of the market by properly analyzing the business, services and activities of the companies such as Illumina, Complete Genomics, and Ambry Genetics. It also provides the competitive benchmarking, taking into account key information such as market value, revenues, risk score etc., along with the strengths and weaknesses of each player. Overall, the report is a complete source of knowledge and statistics for clients who want to get an in-depth understanding of the market.
 
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM672.htm
 
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm